MENU
+Compare
HROW
Stock ticker: NASDAQ
AS OF
Dec 23, 12:21 PM (EDT)
Price
$33.70
Change
-$0.52 (-1.52%)
Capitalization
467.85M

HROW Harrow Forecast, Technical & Fundamental Analysis

a pharmaceutical company

HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for HROW with price predictions
Dec 20, 2024

HROW in +6.76% Uptrend, rising for three consecutive days on December 09, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HROW advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HROW's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

HROW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 04, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on HROW as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HROW turned negative on November 14, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

HROW moved below its 50-day moving average on November 14, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HROW crossed bearishly below the 50-day moving average on November 15, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HROW entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HROW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.398) is normal, around the industry mean (58.252). P/E Ratio (39.526) is within average values for comparable stocks, (90.460). HROW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.207) is also within normal values, averaging (19.472).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HROW is expected to report earnings to fall 210.42% to 13 cents per share on March 13

Harrow HROW Stock Earnings Reports
Q4'24
Est.
$0.13
Q3'24
Missed
by $0.07
Q2'24
Beat
by $0.12
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.22
The last earnings report on November 13 showed earnings per share of -11 cents, missing the estimate of -5 cents. With 20.69K shares outstanding, the current market capitalization sits at 467.85M.
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLVX51.220.89
+1.77%
Lord Abbett Growth Leaders R6
NWHUX30.270.35
+1.17%
Nationwide Bailard Tech & Sci Instl Svc
TCVYX22.730.24
+1.07%
Touchstone Mid Cap Value Y
RYBAX63.580.60
+0.95%
Rydex Basic Materials H
FGDMX111.100.41
+0.37%
Fidelity Advisor Communication ServicesA

HROW and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-0.61%
AMRX - HROW
34%
Loosely correlated
+0.39%
ORGO - HROW
30%
Poorly correlated
-1.93%
AMPH - HROW
28%
Poorly correlated
-0.63%
EBS - HROW
26%
Poorly correlated
+0.50%
RMTI - HROW
26%
Poorly correlated
+1.46%
More